Featured – Past Events
Look below for information on our past events in this series… Never miss an HDRN Canada event! Sign up to our Data Points newsletter
Community Attitudes On Using Health Data in Research
HDRN Canada teamed up with PHRN Australia to deliver an…
Health workforce data in Canada: How to optimize its use within research
HDRN Canada CEO Dr. Kim McGrail appears as a panelist on…
Healthy Data Collective: Healthy Data for Healthy Research
HDRN Canada CEO Dr. Kim McGrail and IDEA Team Chair Dr. Amy Freier share…
Healthy Data Collective: Webinar Series Kickoff
The first webinar in the Healthy Data Collective series explores…
Disruptive Partnership: Charting the Future of pan-Canadian Data & Analytics
HDRN Canada CEO Dr. Kim McGrail joins this panel to…
Community Attitudes On Using Health Data in Research
HDRN Canada teamed up with PHRN Australia to deliver an interactive workshop on public attitudes regarding the use of health data in Canada and Australia, featuring Julia Burt , HDRN Canada’s Public Engagement Lead.
Health workforce data in Canada: How to optimize its use within research
HDRN Canada CEO Dr. Kim McGrail appears as a panelist on this webinar which brings together health workforce researchers, key pan-Canadian data stewards and Health Workforce Canada to discuss the health workforce data available to Canadian researchers and interested stakeholders.
Healthy Data Collective: Healthy Data for Healthy Research
HDRN Canada CEO Dr. Kim McGrail and IDEA Team Chair Dr. Amy Freier share their insights about the importance of collecting and accessing quality health data for research to achieve equity as part of the Healthy Data Collective webinar series.
Healthy Data Collective: Webinar Series Kickoff
The first webinar in the Healthy Data Collective series explores how a collective impact approach can optimize how we use health data in Canada, featuring HDRN Canada CEO Dr. Kim McGrail.
Disruptive Partnership: Charting the Future of pan-Canadian Data & Analytics
HDRN Canada CEO Dr. Kim McGrail joins this panel to explore how “disruptive partnerships” can challenge existing methodologies, introduce novel technologies and pioneer unconventional approaches to improve the effectiveness of drug policy data for better health system outcomes.